Epicardial fat inflammation response to COVID-19 therapies

CONCLUSIONS: Dexamethasone therapy was associated with significant reduction of EAT inflammation in COVID-19 patients, whereas SAT showed no changes. Anti-inflammatory therapies targeting visceral fat may be helpful in COVID-19 diseases.PMID:34028990 | DOI:10.1002/oby.23232
Source: Obesity - Category: Eating Disorders & Weight Management Authors: Source Type: research